- Report
- April 2022
- 325 Pages
Global
From €3277EUR$3,600USD£2,783GBP
- Report
- April 2022
- 101 Pages
North America
From €1365EUR$1,500USD£1,160GBP
- Report
- October 2021
- 366 Pages
Global
From €3641EUR$4,000USD£3,092GBP
- Report
- March 2025
- 75 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- February 2025
- 86 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- July 2024
- 91 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- November 2023
- 87 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- November 2023
- 125 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- July 2024
- 153 Pages
Global
From €3288EUR$3,613USD£2,793GBP
€3868EUR$4,250USD£3,285GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- July 2024
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- November 2021
- 1032 Pages
Global
From €4551EUR$5,000USD£3,865GBP
- Report
- September 2022
- 141 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Book
- January 2024
- 496 Pages
- Book
- April 2015
- 264 Pages

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more